NORDIA PHARMACEUTICAL COMPANY ApS — Credit Rating and Financial Key Figures

CVR number: 18866692
Damvejen 13, 3400 Hillerød
nordia@nordiapharma.dk
tel: 60889200

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales51.69
External services-71.75-52.88-69.21-80.83-32.59
Gross profit-20.05-52.88-69.21-80.83-32.59
Total depreciation-4.41
EBIT-24.46-52.88-69.21-80.83-32.59
Pre-tax profit-24.46-52.88-69.21-80.83-32.59
Net earnings-24.46-52.88-69.21-80.83-32.59

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables4.460.720.100.20
Short term receivables total4.460.720.100.20
Cash and bank deposits16.0816.7416.1313.9412.68
Cash and cash equivalents16.0816.7416.1313.9412.68
Balance sheet total (assets)20.5417.4616.2314.1412.68

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital200.00200.00200.00200.00200.00
Retained earnings- 155.01- 179.47- 232.36- 301.57- 382.39
Profit of the financial year-24.46-52.88-69.21-80.83-32.59
Shareholders equity total20.53-32.36- 101.57- 182.39- 214.98
Non-current liabilities total
Current trade creditors49.80117.80196.54227.66
Other non-interest bearing current liabilities0.020.02
Current liabilities total0.0249.82117.80196.54227.66
Balance sheet total (liabilities)20.5417.4616.2314.1412.68
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.